A year ago, MSD and Daiichi Sankyo's HER3-targeting antibody-drug conjugate patritumab deruxtecan (HER3-DXd) was rejected by ...

Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at ...

The PMCPA also agreed with the complainant that Pfizer had not taken all possible steps to avoid similar breaches in its ...

The award from the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and ...

In a second piece of good news in the development of new antimicrobials this week, GSK has said it will file its oral ...

The verdict of the US district court in New Jersey is that Shilpa's generic infringes a US patent on multikinase inhibitor ...

AstraZeneca has turned to another digital health partner to support its aspirations in chronic kidney disease (CKD), joining forces with Aptar to develop algorithms that can be used to detect CKD ...

The first quarter of 2025 saw a wave of significant advancements in clinical research across oncology, neurology, dermatology, respiratory, and rare diseases. Several biotech and biopharma ...

Ahead of the eyeforpharma Awards we spoke to judge Jennifer Wong – AstraZeneca’s senior director, RWE strategy & alliances, global medical affairs – about why collaboration and RWE are the ...

Health and Human Services (HHS) Secretary Robert F Kennedy Jr at the HELP Committee hearing. US Health and Human Services (HHS) Secretary Robert F Kennedy Jr has made his first testimonies in ...

Biologics now represent around 40% of all pharmaceutical spending in Europe, and they’ve played a major role in transforming treatment outcomes in key disease areas such as cancer, autoimmune ...

As the buzz increases in volume and the clock to kick-off counts down, keep an eye on this Spotlight On page for content ...